Edwards Lifesciences Corporation (EW) financial statements (2023 and earlier)

Company profile

Business Address ONE EDWARDS WAY
IRVINE, CA 92614
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,4671,4031,5179571,3381,2711,225
Cash and cash equivalents8631,1831,179714818930718
Short-term investments604219338242519341506
Restricted cash and investments217     
Receivables582515544457422366315
Inventory, net of allowances, customer advances and progress billings727802641607555397340
Inventory727802641607555397340
Prepaid expense85755954614645
Other current assets23720816813211711294
Other undisclosed current assets81725680414929
Total current assets:3,1813,0912,9842,2872,5322,2402,048
Noncurrent Assets
Operating lease, right-of-use asset929480
Property, plant and equipment1,5471,3951,060868680580483
Long-term investments and receivables1,834802586506567532384
Long-term investments1,834802586506567532380
Accounts and financing receivable, after allowance for credit loss      4
Intangible assets, net (including goodwill)1,4921,5051,5041,4551,595831834
Goodwill1,1681,1731,1681,1121,127626628
Intangible assets, net (excluding goodwill)324331337343468205205
Deferred income tax assets247231172
Other noncurrent assets11112010234109123131
Deferred tax assets, net  204181
Other undisclosed noncurrent assets   174214  
Total noncurrent assets:5,3224,1463,5043,0373,1642,2702,011
TOTAL ASSETS:8,5037,2376,4885,3245,6964,5104,059
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities674562647496562410141
Accounts payable2051971801341179764
Accrued liabilities120110117104989163
Employee-related liabilities320237296226249216 
Taxes payable3119533198615
Debt  26 598  
Derivative instruments and hedges, liabilities439642534
Restructuring reserve19151708 19
Estimated litigation liability 38201971586
Business combination, contingent consideration, liability    52  
Other undisclosed current liabilities335241187180144111306
Total current liabilities:1,0328949028771,403533476
Noncurrent Liabilities
Long-term debt and lease obligation665668653594438822600
Long-term debt, excluding current maturities596595594594438822600
Operating lease, liability697359
Liabilities, other than long-term debt780886548454504536480
Liability for uncertainty in income taxes259214172125165230195
Estimated litigation liability191233     
Other liabilities267252203150147306285
Business combination, contingent consideration, liability62186173179193  
Other undisclosed noncurrent liabilities190      
Total noncurrent liabilities:1,6341,5541,2011,0479431,3591,080
Total liabilities:2,6672,4482,1031,9242,3461,8911,556
Stockholders' equity
Stockholders' equity attributable to parent5,8364,5744,1483,1402,9562,6192,503
Common stock642636218215212243239
Treasury stock, value(2,417)(1,904)(1,279)(1,015)(252)(2,499)(1,837)
Additional paid in capital1,7001,4381,6231,3841,1671,168947
Accumulated other comprehensive loss(158)(161)(156)(139)(133)(198)(183)
Retained earnings6,0684,5653,7422,6951,9623,9063,337
Total stockholders' equity:5,8364,5744,1483,1402,9562,6192,503
Other undisclosed liabilities and equity 215237259394  
TOTAL LIABILITIES AND EQUITY:8,5037,2376,4885,3245,6964,5104,059

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues5,2334,3864,3483,7233,4352,9642,494
Revenue, net3,4352,9642,494
Cost of revenue
(Cost of Goods and Services Sold)
(1,249)(1,081)(1,114)(939)(875)(797)(617)
Gross profit:3,9843,3063,2342,7832,5602,1661,877
Operating expenses(2,417)(2,395)(2,028)(1,925)(1,464)(1,381)(1,234)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
  (65)(116)(60)(35) 
Other undisclosed operating income (loss)124(14)66   
Operating income:1,6908981,1477481,036751643
Nonoperating income303540361263
Investment income, nonoperating1723323220118
Foreign currency transaction loss, before tax      (5)
Other nonoperating income (expense)131284(8)(5) 
Interest and debt expense(18)(16)(21)(30)(23)(19)(17)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   710 (6)
Income from continuing operations before income taxes:1,7029171,1677611,035738622
Income tax expense(199)(93)(120)(39)(451)(168)(128)
Net income available to common stockholders, diluted:1,5038231,047722584570495

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:1,5038231,047722584570495
Other comprehensive income (loss)   (16)32  
Comprehensive income:1,5038231,047706616570495
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3(5)(18)1834(16)(82)
Comprehensive income, net of tax, attributable to parent:1,5078181,029724649554413

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: